Results of radical prostatectomy in men with clinically localized prostate cancer

G. S. Gerber, R. A. Thisted, P. T. Scardino, H. G. Frohmuller, F. H. Schroeder, D. F. Paulson, A. W. Middleton Jr, D. B. Rukstalis, J. A. Smith Jr, P. F. Schellhammer, M. Ohori and G. W. Chodak
Section of Urology, Department of Surgery, University of Chicago (III) Pritzker School of Medicine, IL 60637, USA.

OBJECTIVE: To assess the results of radical prostatectomy in men with early prostate cancer. DESIGN: Retrospective, nonrandomized, multi-institutional pooled analysis. SETTING: Eight university medical centers in the United States and Europe. PATIENTS: A total of 2758 men with stage Tl and T2 prostatic cancer. MAIN OUTCOME MEASURES: Disease-specific and metastasis-free survival rates. RESULTS: Tumor grade was the most important preoperative factor in determining outcome. Disease-specific survival 10 years following surgery and associated 95% confidence intervals were 94% (range, 87%-98%), 80% (range, 74%-85%), and 77% (range, 65%-86%) for those men with grade 1, 2, and 3 tumors, respectively. Metastasis-free survival at 10 years was 87% (range, 78%-92%), 68% (range, 62%-73%), and 52% (range, 38%-64%) for patients with grade 1, 2, and 3 cancers, respectively. CONCLUSIONS: Radical prostatectomy leads to high 10-year disease-specific survival rates in men with all tumor grades. However, caution is needed in comparing these results with similar studies of alternative treatment strategies, such as watchful waiting, due to the inherent potential biases in uncontrolled trials. Nevertheless, these results offer the best currently available estimates of 10-year outcome of radical prostatectomy in men with clinically localized prostate cancer and may be useful in counseling patients with early malignancy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Canine Prostate: Contrast-enhanced US-guided Radiofrequency Ablation with Urethral and Neurovascular Cooling--Initial Experience
Liu et al.
Radiology 2008;247:717-725.
ABSTRACT | FULL TEXT  

Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911
Van der Kwast et al.
JCO 2007;25:4178-4186.
ABSTRACT | FULL TEXT  

A Randomized Trial Comparing Radical Prostatectomy Plus Endocrine Therapy versus External Beam Radiotherapy Plus Endocrine Therapy for Locally Advanced Prostate Cancer: Results at Median Follow-up of 102 Months
Akakura et al.
Jpn J Clin Oncol 2006;36:789-793.
ABSTRACT | FULL TEXT  

2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy
Schoder et al.
Clin. Cancer Res. 2005;11:4761-4769.
ABSTRACT | FULL TEXT  

Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer
Labrie et al.
Endocr. Rev. 2005;26:361-379.
ABSTRACT | FULL TEXT  

Predictor of Response to Salvage Radiotherapy in Patients with PSA Recurrence after Radical Prostatectomy: the Usefulness of PSA Doubling Time
Numata et al.
Jpn J Clin Oncol 2005;35:256-259.
ABSTRACT | FULL TEXT  

Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy
Miller et al.
JCO 2005;23:2772-2780.
ABSTRACT | FULL TEXT  

Implications of the Prostate Cancer Prevention Trial: A Decision Analysis Model of Survival Outcomes
Lotan et al.
JCO 2005;23:1911-1920.
ABSTRACT | FULL TEXT  

Natural History of Early, Localized Prostate Cancer
Johansson et al.
JAMA 2004;291:2713-2719.
ABSTRACT | FULL TEXT  

Caring for a Spouse after Prostate Surgery: The Preparedness Needs of Wives
Giarelli et al.
Journal of Family Nursing 2003;9:453-485.
ABSTRACT  

Do Older Men Benefit From Curative Therapy of Localized Prostate Cancer?
Alibhai et al.
JCO 2003;21:3318-3327.
ABSTRACT | FULL TEXT  

How are we looking after prostate cancer?
WAXMAN and MAZHAR
QJM 2003;96:75-79.
FULL TEXT  

Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
Harris and Lohr
ANN INTERN MED 2002;137:917-929.
ABSTRACT | FULL TEXT  

A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg et al.
NEJM 2002;347:781-789.
ABSTRACT | FULL TEXT  

Salvage Cryotherapy for Recurrent Prostate Cancer After Radiotherapy: Variables Affecting Patient Outcome
Izawa et al.
JCO 2002;20:2664-2671.
ABSTRACT | FULL TEXT  

Local Recurrence after Radical Prostatectomy: Correlation of US Features with Prostatic Fossa Biopsy Findings
Leventis et al.
Radiology 2001;219:432-439.
ABSTRACT | FULL TEXT  

Prostate Cancer: What Is the Future Role for Imaging?
Thornbury et al.
Am. J. Roentgenol. 2001;176:17-22.
FULL TEXT  

Preoperative Prediction of Surgical Margin Status in Patients With Prostate Cancer Treated by Radical Prostatectomy
Cheng et al.
JCO 2000;18:2862-2868.
ABSTRACT | FULL TEXT  

Genitourinary Consequences of Radical Prostatectomy
Rockoff and Hennenfent
JAMA 2000;283:2932-2932.
FULL TEXT  

The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model
Grover et al.
CMAJ 2000;162:977-983.
ABSTRACT | FULL TEXT  

The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model
Grover et al.
CMAJ 2000;162:987-992.
ABSTRACT | FULL TEXT  

Serum Human Glandular Kallikrein-2 Protease Levels Predict the Presence of Prostate Cancer Among Men With Elevated Prostate-Specific Antigen
Nam et al.
JCO 2000;18:1036-1036.
ABSTRACT | FULL TEXT  

PSA screening: the bottom line
Elhilali
CMAJ 2000;162:791-792.
FULL TEXT  

Localised prostate cancer: can we do better?
Prior and Waxman
BMJ 2000;320:69-70.
FULL TEXT  

Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound et al.
JAMA 1999;281:1591-1597.
ABSTRACT | FULL TEXT  

Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis
Shipley et al.
JAMA 1999;281:1598-1604.
ABSTRACT | FULL TEXT  

The Danger of Applying Group-level Utilities in Decision Analyses of the Treatment of Localized Prostate Cancer in Individual Patients
Cowen et al.
Med Decis Making 1998;18:376-380.
ABSTRACT  

Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer
Albertsen et al.
JAMA 1998;280:975-980.
ABSTRACT | FULL TEXT  

GOOD OUTCOMES WITH RADICAL PROSTATECTOMY
JWatch General 1996;1996:5-5.
FULL TEXT